Sionna Therapeutics, Inc.
SION · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $51 | $41 | $83 | $38 |
| Short-Term Investments | $197 | $222 | $187 | $110 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $4 | $3 |
| Total Curr. Assets | $252 | $267 | $274 | $151 |
| Property Plant & Equip (Net) | $9 | $10 | $10 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $78 | $76 | $85 | $21 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $4 |
| Total NC Assets | $87 | $85 | $96 | $35 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $339 | $352 | $370 | $186 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $5 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $5 | $3 | $8 |
| Total Curr. Liab. | $10 | $8 | $10 | $10 |
| LT Debt | $8 | $8 | $8 | $9 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $330 |
| Total NC Liab. | $8 | $8 | $8 | $339 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $9 | $9 | $10 |
| Total Liabilities | $18 | $16 | $18 | $349 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $330 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$236 | -$216 | -$198 | -$181 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $557 | $552 | $549 | -$313 |
| Total Equity | $322 | $336 | $352 | -$164 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $339 | $352 | $370 | $186 |
| Net Debt | -$42 | -$32 | -$73 | -$28 |